6,8-Di-chloro-3-(pyridin-2-yl)-2-[1-(pyridin-2-yl)eth-yl]-1,2-di-hydro-quinoxaline.

ABSTRACT: The crystal structure of the racemic title compound, C₂₀H₁₆C_l2N₄ is described, where the formation of a di-substituted 6,8-di-chloro quinoxaline, containing two stereogenic centres, is confirmed.

SUBMITTER: Malan FP 

PROVIDER: S-EPMC10483544 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature